ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Cidara Therapeutics Inc

Cidara Therapeutics Inc (CDTX)

19,59
0,90
(4,82%)
Beim Schlusskurs: 26 November 10:00PM
19,59
0,00
( 0,00% )
Nach Börsenschluss: 10:30PM

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Current Price
19,59
Gebot
18,60
Fragen
20,44
Volumen
32.883
17,82 Tagesbereich 20,20
10,004 52-Wochen-Bereich 24,40
Marktkapitalisierung
Handelsende
18,69
Handelsbeginn
18,63
Letzte Trade
50
@
18.6668
Letzter Handelszeitpunkt
22:25:55
Finanzvolumen
US$ 629.746
VWAP
19,1511
Durchschnittliches Volumen (3 Mio.)
37.063
Ausgegebene Aktien
7.046.633
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-5,93
Gewinn pro Aktie (EPS)
-3,25
Erlöse
63,91M
Nettogewinn
-22,93M

Über Cidara Therapeutics Inc

Cidara Therapeutics Inc is a biotechnology company. It is focused on the discovery, development, and commercialization of novel anti-infectives for the treatment and prevention of diseases. The company's Rezafungin is a novel molecule in the echinocandin class of antifungals. It is developing rezafu... Cidara Therapeutics Inc is a biotechnology company. It is focused on the discovery, development, and commercialization of novel anti-infectives for the treatment and prevention of diseases. The company's Rezafungin is a novel molecule in the echinocandin class of antifungals. It is developing rezafungin for the first-line treatment and prevention of serious, invasive fungal infections which are associated with high mortality rates. Mehr anzeigen

Sektor
Biological Pds,ex Diagnstics
Branche
Biological Pds,ex Diagnstics
Website
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Cidara Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker CDTX. The last closing price for Cidara Therapeutics was US$18,69. Over the last year, Cidara Therapeutics shares have traded in a share price range of US$ 10,004 to US$ 24,40.

Cidara Therapeutics currently has 7.046.633 shares in issue. The market capitalisation of Cidara Therapeutics is US$131,70 million. Cidara Therapeutics has a price to earnings ratio (PE ratio) of -5.93.

CDTX Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
14.6631.212324179514.9321.28414.7719496918.78094086CS
46.9855.352894528212.6121.28412.547171117.65438353CS
127.8266.440101954111.7721.28410.143706315.52598081CS
267.5963.251221.28410.143483813.98104087CS
525.2936.99300699314.324.410.00434089615.44835974CS
156-9.21-31.979166666728.842874038323.01272497CS
260-30.21-60.662650602449.889862067730.80948772CS
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
IFBDInfobird Company Ltd
US$ 3,35
(84,07%)
3,04M
MTEMMolecular Templates Inc
US$ 0,4734
(27,95%)
1,55M
AMBAAmbarella Inc
US$ 83,31
(21,78%)
426,5k
EVTVEnvirotech Vehicles Inc
US$ 1,54
(14,07%)
389,74k
TRIBTrinity Biotech PLC
US$ 1,28
(12,28%)
300
PGHLPrimega Group Holdings Ltd
US$ 12,75
(-88,12%)
1,18M
BSFCBlue Star Foods Corporation
US$ 0,311
(-15,95%)
2,1M
IMGCIMG Inc
US$ 1,35
(-15,63%)
2,25M
ZENAZenaTech Inc
US$ 9,25
(-10,19%)
634,11k
KWEKWESST Micro Systems Inc
US$ 0,72
(-9,43%)
16,21k
ELABElevai Labs Inc
US$ 0,0121
(-3,20%)
10,09M
IGFiShares Global Infrastructure
US$ 55,25
(0,00%)
4,76M
IDAIT Stamp Inc
US$ 0,3958
(8,44%)
4,04M
NKLANikola Corporation
US$ 1,96
(0,51%)
3,06M
IFBDInfobird Company Ltd
US$ 3,35
(84,07%)
3,04M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock